Report Detail

According to our (Global Info Research) latest study, the global In-Vitro Colorectal Cancer Screening Tests market size was valued at US$ 1255 million in 2025 and is forecast to a readjusted size of US$ 1803 million by 2032 with a CAGR of 5.4% during review period.
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
The industry"s leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.
This report is a detailed and comprehensive analysis for global In-Vitro Colorectal Cancer Screening Tests market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global In-Vitro Colorectal Cancer Screening Tests market size and forecasts, in consumption value ($ Million), 2021-2032
Global In-Vitro Colorectal Cancer Screening Tests market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global In-Vitro Colorectal Cancer Screening Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global In-Vitro Colorectal Cancer Screening Tests market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In-Vitro Colorectal Cancer Screening Tests
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In-Vitro Colorectal Cancer Screening Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
In-Vitro Colorectal Cancer Screening Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
Market segment by Application
Hospital and Clinics
Ambulatory
Home Care
Market segment by players, this report covers
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In-Vitro Colorectal Cancer Screening Tests product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In-Vitro Colorectal Cancer Screening Tests, with revenue, gross margin, and global market share of In-Vitro Colorectal Cancer Screening Tests from 2021 to 2026.
Chapter 3, the In-Vitro Colorectal Cancer Screening Tests competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and In-Vitro Colorectal Cancer Screening Tests market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In-Vitro Colorectal Cancer Screening Tests.
Chapter 13, to describe In-Vitro Colorectal Cancer Screening Tests research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of In-Vitro Colorectal Cancer Screening Tests by Type
    • 1.3.1 Overview: Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global In-Vitro Colorectal Cancer Screening Tests Consumption Value Market Share by Type in 2025
    • 1.3.3 Biomarker Tests
    • 1.3.4 Fecal Occult Blood Tests
    • 1.3.5 CRC DNA Screening Tests
  • 1.4 Global In-Vitro Colorectal Cancer Screening Tests Market by Application
    • 1.4.1 Overview: Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinics
    • 1.4.3 Ambulatory
    • 1.4.4 Home Care
  • 1.5 Global In-Vitro Colorectal Cancer Screening Tests Market Size & Forecast
  • 1.6 Global In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast by Region
    • 1.6.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region, (2021-2032)
    • 1.6.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2021-2032)
    • 1.6.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2021-2032)
    • 1.6.6 South America In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Alere(Abbott)
    • 2.1.1 Alere(Abbott) Details
    • 2.1.2 Alere(Abbott) Major Business
    • 2.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Alere(Abbott) Recent Developments and Future Plans
  • 2.2 Beckman Coulter
    • 2.2.1 Beckman Coulter Details
    • 2.2.2 Beckman Coulter Major Business
    • 2.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Beckman Coulter Recent Developments and Future Plans
  • 2.3 Siemens Healthcare
    • 2.3.1 Siemens Healthcare Details
    • 2.3.2 Siemens Healthcare Major Business
    • 2.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Siemens Healthcare Recent Developments and Future Plans
  • 2.4 Eiken Chemical
    • 2.4.1 Eiken Chemical Details
    • 2.4.2 Eiken Chemical Major Business
    • 2.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Eiken Chemical Recent Developments and Future Plans
  • 2.5 Hitachi Chemical (Kyowa Medex)
    • 2.5.1 Hitachi Chemical (Kyowa Medex) Details
    • 2.5.2 Hitachi Chemical (Kyowa Medex) Major Business
    • 2.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments and Future Plans
  • 2.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
    • 2.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Details
    • 2.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Major Business
    • 2.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments and Future Plans
  • 2.7 Sysmex
    • 2.7.1 Sysmex Details
    • 2.7.2 Sysmex Major Business
    • 2.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sysmex Recent Developments and Future Plans
  • 2.8 QIAGEN
    • 2.8.1 QIAGEN Details
    • 2.8.2 QIAGEN Major Business
    • 2.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 QIAGEN Recent Developments and Future Plans
  • 2.9 R-Biopharm
    • 2.9.1 R-Biopharm Details
    • 2.9.2 R-Biopharm Major Business
    • 2.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 R-Biopharm Recent Developments and Future Plans
  • 2.10 Immunostics
    • 2.10.1 Immunostics Details
    • 2.10.2 Immunostics Major Business
    • 2.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Product and Solutions
    • 2.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Immunostics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of In-Vitro Colorectal Cancer Screening Tests by Company Revenue
    • 3.2.2 Top 3 In-Vitro Colorectal Cancer Screening Tests Players Market Share in 2025
    • 3.2.3 Top 6 In-Vitro Colorectal Cancer Screening Tests Players Market Share in 2025
  • 3.3 In-Vitro Colorectal Cancer Screening Tests Market: Overall Company Footprint Analysis
    • 3.3.1 In-Vitro Colorectal Cancer Screening Tests Market: Region Footprint
    • 3.3.2 In-Vitro Colorectal Cancer Screening Tests Market: Company Product Type Footprint
    • 3.3.3 In-Vitro Colorectal Cancer Screening Tests Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global In-Vitro Colorectal Cancer Screening Tests Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global In-Vitro Colorectal Cancer Screening Tests Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America In-Vitro Colorectal Cancer Screening Tests Consumption Value by Type (2021-2032)
  • 6.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2032)
  • 6.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
    • 6.3.1 North America In-Vitro Colorectal Cancer Screening Tests Consumption Value by Country (2021-2032)
    • 6.3.2 United States In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 6.3.3 Canada In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe In-Vitro Colorectal Cancer Screening Tests Consumption Value by Type (2021-2032)
  • 7.2 Europe In-Vitro Colorectal Cancer Screening Tests Consumption Value by Application (2021-2032)
  • 7.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country
    • 7.3.1 Europe In-Vitro Colorectal Cancer Screening Tests Consumption Value by Country (2021-2032)
    • 7.3.2 Germany In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 7.3.3 France In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 7.3.5 Russia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 7.3.6 Italy In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region
    • 8.3.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Consumption Value by Region (2021-2032)
    • 8.3.2 China In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 8.3.3 Japan In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 8.3.5 India In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 8.3.7 Australia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America In-Vitro Colorectal Cancer Screening Tests Consumption Value by Type (2021-2032)
  • 9.2 South America In-Vitro Colorectal Cancer Screening Tests Consumption Value by Application (2021-2032)
  • 9.3 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
    • 9.3.1 South America In-Vitro Colorectal Cancer Screening Tests Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country
    • 10.3.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)
    • 10.3.4 UAE In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 In-Vitro Colorectal Cancer Screening Tests Market Drivers
  • 11.2 In-Vitro Colorectal Cancer Screening Tests Market Restraints
  • 11.3 In-Vitro Colorectal Cancer Screening Tests Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 In-Vitro Colorectal Cancer Screening Tests Industry Chain
  • 12.2 In-Vitro Colorectal Cancer Screening Tests Upstream Analysis
  • 12.3 In-Vitro Colorectal Cancer Screening Tests Midstream Analysis
  • 12.4 In-Vitro Colorectal Cancer Screening Tests Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on In-Vitro Colorectal Cancer Screening Tests. Industry analysis & Market Report on In-Vitro Colorectal Cancer Screening Tests is a syndicated market report, published as Global In-Vitro Colorectal Cancer Screening Tests Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of In-Vitro Colorectal Cancer Screening Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report